Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.180
Buy
RSI(14)
53.275
Neutral
STOCH(KDJ)(9,3,3)
61.683
Neutral
ATR(14)
2.761
Low Volatility
CCI(14)
39.283
Neutral
Williams %R
37.583
Buy
TRIX(12,20)
0.208
Sell
StochRSI(14)
84.085
Overbought
Search
Nanobiotix SA
NBTXAdd to Watchlist
39.700USD
+0.150+0.38%
Close 07-24 16:00（ET）Quotes delayed by 15 min
2.02BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+0.38%
5 Days
+5.05%
1 Month
+10.31%
6 Months
+84.48%
Year to Date
+71.71%
1 Year
+482.97%
Key Figures
40.260Open
40.400High
103.75KVolume
LossP/E TTM
128.16P/E Dynamic
--Dividend TTM
0.21%Turnover Ratio
39.550Prev. Close
39.120Low
1.60MTurnover
LossP/E Static
-19.62P/B
0.00%Div Yield TTM
-84.47%ROA
57.14052wk High
0.79Volume Ratio
-68.13MNet Profit
48.39MShares
-1.3923EPS TTM
0.73Beta
--ROE
4.06152wk Low
3.24%Amplitude
100.00%Gross Margin
2.02BMarket Cap
2.37Reward/Risk
4.17%Risk Rate
Nanobiotix SA News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
7
analysts
Buy
Current Rating
53.000
Target Price
+34.01%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Nanobiotix SA
NBTX
7
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
38.956
Buy
MA10
39.085
Buy
MA20
38.805
Buy
MA50
39.198
Buy
MA100
36.549
Buy
MA200
29.479
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Nanobiotix SA Info
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Ticker SymbolNBTX
CompanyNanobiotix SA
CEOLevy (Laurent)
Websitehttps://www.nanobiotix.com
Shareholders
Related Instruments
+0.88%
+1.60%
+0.90%
+0.46%
-0.72%
+0.43%
+1.22%
+1.25%
-1.18%
-0.12%
+0.94%
+0.90%
+1.20%
-0.02%
+2.04%
0.00%
+0.63%
-0.69%
+2.59%
+0.89%Popular Instruments
52478.200
+578.200 (+1.11%)
28603.300
+452.900 (+1.61%)
7487.900
+79.800 (+1.08%)
15117.000
+169.000 (+1.13%)
65151.000
+932.000 (+1.45%)
6357.900
+93.400 (+1.49%)
81.967
-8.076 (-8.97%)
333.020
+11.360 (+3.53%)
206.840
-1.920 (-0.92%)
4097.320
+44.970 (+1.11%)
FAQs
What is the current price of Nanobiotix SA (NBTX)?
The current price of Nanobiotix SA (NBTX) is 39.70.
What is the symbol of Nanobiotix SA?
The ticker symbol of Nanobiotix SA is NBTX.
What is the 52-week high of Nanobiotix SA?
The 52-week high of Nanobiotix SA is 57.14.
What is the 52-week low of Nanobiotix SA?
The 52-week low of Nanobiotix SA is 4.06.
What is the market capitalization of Nanobiotix SA?
The market capitalization of Nanobiotix SA is 2.02B.
Is Nanobiotix SA (NBTX) currently rated as Buy, Hold, or Sell?
According to analysts, Nanobiotix SA (NBTX) has an overall rating of Buy, with a price target of 53.00.
What is the Earnings Per Share (EPS TTM) of Nanobiotix SA (NBTX)?
The Earnings Per Share (EPS TTM) of Nanobiotix SA (NBTX) is -0.59.